Introduction
At present, the unborn child is increasingly being treated as a patient in its own right. Thanks to advances in high resolution ultrasound and other diagnostic techniques, an increasing number of conditions are diagnosed early in gestation and insight into their pathophysiology has also been gained. Some of these conditions are life-threatening in utero or result in irreversible organ damage and may benefit from prenatal surgical intervention.
From being an experimental technique, only performed by a few audacious surgeons and obstetricians, fetal surgery has evolved into a more mainstream form of treatment for some prenatally diagnosed fetal or placental conditions [1] . Depending on the pathology, different approaches for fetal interventions are possible, with different levels of invasiveness. Providing anesthesia for procedures ranging from complex open surgery to minimally invasive ultrasound-guided procedures [2, 3] can be challenging.
Open fetal surgery, for example, is performed in cases of severe myelomeningocele, where prenatal closure gives better results in survival and neurologic functioning than postnatal repair [4, 5] . Also large sacral teratomas and cystic lung lesions can be resected if there is a severe impact on the further viability of the fetus [3] .
Endoscopic surgery on the fetus, for example, is performed in the case of congenital diaphragmatic hernia, where growth of the hypoplastic lung is induced and accelerated by plugging the fetal trachea with a balloon, the FETO procedure [6, 7] . Other endoscopic procedures on the fetus are vesicoamniotic shunts for lower urinary tract occlusion or other shunting procedures, such as for pleural effusions [2] .
Endoscopic surgery on the placenta and membranes is performed for twin-to-twin transfusion syndrome, where laser ablation of connecting vessels gives better results than expectant management with serial amniodrainages [8] [9] [10] . Other abnormalities of monochorionic twins sometimes warrant a selective reduction of the pregnancy to protect the viable twin. In these cases, a selective feticide can be performed with an endoscopic laser, bipolar or radiofrequency coagulation of one cord [11, 12] .
Where other fetal procedures are performed in the second or early third trimester of pregnancy, the ex utero intrapartum treatment (EXIT) procedure is performed near term, often with the aim of securing the fetal airways before birth, immediately before delivering the fetus through a cesarian section. While the fetus is still oxygenated on the placental circulation, the airways can be secured or an extracorporeal membrane oxygenator can be connected before the placental cord is clamped [13, 14] .
In this review, specific aspects of anesthesia for fetal surgical procedures are described, looking from both the maternal and the fetal point of view. [15] Respiratory System Airway management becomes increasingly demanding when gestation progresses because of increased body weight, short neck, enlarged breasts, nasopharyngeal edema and capillary engorgement and the increased susceptibility of the nasopharynx to be traumatized [16, 17] . Oxygen consumption is increased as well as alveolar ventilation. As a result respiratory alkalosis is present during pregnancy. Functional residual capacity is decreased by approximately 20% [18] .
Maternal Anesthetic Aspects of Fetal Surgery

Physiologic Changes of Pregnancy and Their Impact on Anesthetic Management
The pregnant patient is more prone to hypoxia because of decreased functional residual capacity and increased oxygen consumption [19] . Careful denitrogenation prior to the induction of general anesthesia is therefore recommended. The physiologic mild respiratory alkalosis should be maintained during artificial ventilation since both hypercarbia or very low levels of carbon dioxide can compromise uteroplacental perfusion.
Cardiovascular System
Plasma volume increases by approximately 45%. A state of hypercoagulability develops. Cardiac output, stroke volume and heart rate are increased. Myocardial contractility is unchanged and systemic vascular resistance is decreased [18] . The enlarging uterus causes compression of the inferior vena cava and the aorta resulting in the so-called supine hypotensive syndrome. Many conditions that are treated by fetal surgery also present with polyhydramnios [20] , increasing the risk for caval compression, so prevention by use of a left lateral tilt position is important.
Pregnant patients are more prone to thromboembolic complications and adequate prophylactic measures should be taken including prophylactic administration of low-molecular-weight heparins [18, 21] .
Gastrointestinal Changes
The enlarging uterus causes increased intragastric pressure. Combined with a decreased lower esophageal sphincter tone and increased gastric acid secretion, the chance of gastric regurgitation is increased. Acid aspiration prophylaxis (in our institution a combination of an H 2 receptor antagonist, sodium citrate orally 30 ml 0.3 M and metoclopramide) is therefore recommended to reduce gastric secretion and increase gastric pH [22] .
Central Nervous System Central nervous system depression occurs secondary to increased progesterone levels. The epidural space capacity is reduced due to engorgement of the epidural venous plexus [23, 24] . Pregnancy is associated with a decreased minimal alveolar concentration of volatile anesthetics [25] and a higher sensitivity to local anesthetics [23] .
The combined changes in physiology during pregnancy predispose the pregnant patient to higher risks when general anesthesia is performed, making local or regional anesthesia a safer option when possible [26] . ( table 1 ) General and regional anesthesia can be performed, depending on the type of procedure [15] .
Anesthetic Techniques for Fetal Surgical Interventions
Open Fetal Surgery
A general anesthetic is usually needed for the maternal laparotomy and hysterotomy [20] . After a rapid sequence induction, when volatile anesthetics are used to maintain anesthesia, at least 2 MAC is used for profound uterine relaxation. Intravenous anesthesia can be supplemented with volatiles for uterine relaxation [27] . If needed, intravenous nitroglycerin can also be used for short-lasting uterine relaxation [28, 29] . The use of high concentrations of volatiles and nitroglycerin often necessitates vasopressor support for adequate uteroplacental perfusion. Invasive monitoring of the arterial blood pressure is required, and a central venous line is often placed. There is a risk of postoperative pulmonary edema, so fluids should be restricted [27, 30] .
Adequate postoperative pain control is necessary for the prevention of uterine contractions and premature delivery, for example with epidural patient-controlled analgesia. Circulating oxytocin concentrations were lower in an animal model of open fetal surgery when adequate postoperative analgesia was provided with morphine infusions [31] . Prophylactic tocolysis is started preoperatively with rectal indomethacin 50 mg, and postoperative tocolysis can be provided, together with adequate analgesia, by a magnesium sulphate infusion [3] . Careful monitoring of the recovery of the neuromuscular function is required, since magnesium sulphate potentiates nondepolarizing neuromuscular blockers. Other tocolytic drugs that can be used postoperatively are intravenous atosiban, oral nifedipine or subcutaneous terbutaline. In addition to fluid overload, some tocolytic regimens can also contribute to the development of pulmonary edema [32] .
Frequent complications after open fetal surgery are pulmonary edema, premature labor, amniotic fluid leak and fetal demise. Sometimes admission to ICU may be necessary [30] .
Because of the risks for major maternal and fetal morbidity, many open fetal procedures are attempted to perform less invasively, with the development of new fetoscopic techniques [1] .
Minimally Invasive Fetal Surgery
Minimally invasive procedures include ultrasoundguided needling for fetal blood sampling, intrauterine transfusion, selective feticide, radiofrequency ablation of a nonviable twin [11] or fetal cardiac puncture for laser atrial septostomy [33] . Fetoscopic procedures (intrauterine endoscopic surgery) are performed for laser coagulation of connecting vessels in twin-to-twin transfusion syndrome [8] , selective cord occlusion [12] , fetal endoscopic tracheal balloon occlusion and the subsequent removal of the tracheal balloon [6] or the resection of urethral valves [34] .
These procedures are less invasive for the mother, so general anesthesia is not always necessary [30] . Many ultrasound-guided needling procedures can be performed using local anesthesia of the maternal abdominal wall alone [35] . For most fetoscopic procedures either a local anesthetic or regional anesthesia such as epidural or combined spinal epidural anesthesia is used [36] . If general anesthesia is necessary, the same type of anesthesia as for open fetal procedures can be used. However, the concentrations of volatile anesthetics do not need to be as high because the trauma to the uterus and the uterine activity is less [37] .
When using a local or regional anesthesia technique, the fetus does not receive any anesthesia or analgesia [36] . When the mother is lightly sedated by an intravenous infusion of remifentanil, transplacental passage also provides immobilization of the fetus [38] .
EXIT Procedures These procedures are mostly performed with a general anesthesia comparable to open fetal surgery, with high concentrations of volatile anesthetics to ensure uterine relaxation [39] . Uterine relaxation is needed to prevent placental separation and to preserve the uteroplacental circulation. Since the uteroplacental circulation is dependent on maternal hemodynamic stability, ino tropes, vasopressors or fluids may be used for treatment of maternal hypotension. Invasive monitoring is highly recommended for the prevention of maternal hypotension, with decreased uteroplacental perfusion [40, 41] .
When a general anesthetic is not possible (for example, for patients at risk of malignant hyperthermia or with a known difficult airway [42] ), a regional technique, CSE or continuous spinal anesthesia, can be used with intravenous nitroglycerin to provide a rapidly reversible, profound uterine relaxation [28, 29, 43] .
There is a risk of major intraoperative and postoperative maternal blood loss particularly during lengthy procedures. Postoperative blood loss is associated with uterine atony, possibly due to the prolonged effects of tocolytics [41, 44] .
Fetal Anesthetic Aspects of Fetal Surgery
Fetal Effects of Anesthesia
Teratogenic Effects Are anesthetic agents teratogenic? Several factors determine whether a drug is teratogenic or not. Especially the timing of exposure to the drug and the dose of the anesthetic drug used seem to be important determining factors. Anesthetic agents, at clinically relevant concentrations, have potentially harmful effects on cells, including decreased cell motility, prolongation of DNA synthesis and inhibition of cell cleavage [45] . Despite these concerns, no data are available to link teratogenicity with these agents in humans. Prospective, randomized trials are impractical and often considered unethical. Research has focussed therefore on animal data, epidemiological surveys and reports of pregnancy outcome in women who have undergone surgery during pregnancy. Opioids seem to be devoid of teratogenic effects in both animal and human studies [46, 47] . Benzodiazepines became controversial after reports of an association between cleft palate and maternal diazepam ingestion during the first trimester [48] . However, subsequent prospective reports failed to confirm this association. A single dose of benzodiazepines for preoperative anxiolysis can safely be used [49, 50] . Teratogenesis has also not been associated with the use of any commonly used induction agents [51] . Clinically relevant doses of commonly used muscle relaxants are also safe [52] . No evidence supports teratogenicity associated with local anesthetics used in clinically relevant doses [53] . If normal homeostasis is maintained, also halogenated agents also seem to be safe. Nitrous oxide is a weak teratogen used in animal studies and cell cultures, but this was not demonstrated in clinical use in pregnant patients. Concerns about teratogenicity of nitrous oxide are mainly focussed on long-term occupational exposure to low concentrations [54] .
Effects of Anesthetic Drugs on Brain Development [55] Since an initial report in 2003 about possible negative effects of anesthesia administered early in life on brain development, much concern and debate have risen over the safety of anesthesia in young children. In one publication [56] , neonatal rats were subjected to a prolonged period of anesthesia, leading to a deficit in spatial recognition tasks at later ages. These findings were later reproduced also in other species, including primates [57] .
The pathophysiologic basis for these effects on brain development is partially attributed to anesthesia-related neurodegeneration, with an increase in neuroapoptosis above the normal developmental apoptosis which occurs during normal brain development [58] . Other contributing pathophysiologic pathways are the effects of anesthesia on synaptogenesis, with reduced dendritic spine density after propofol exposure in rats [59] and decreased neurogenesis with effects on neural plasticity [60] .
Although the evidence for impaired neurodevelopment after early anesthetic exposure is corroborated by different animal studies, it is still unclear whether this has any clinical implications for anesthesia in human children. The effects of surgery with anesthesia in early childhood are studied with large cohort studies, but either the studies were unable to differentiate between the effects of anesthesia and the effects of surgery and the associated pathology [61] , or they were unable to demonstrate an effect of anesthesia on the incidence of learning disabilities [62] . More research is ongoing in this rapidly evolving field, and no definite conclusions are yet available.
Indirect Effects of Anesthetic Drugs on the Fetus
Intrauterine asphyxia is the most important fetal risk associated with maternal surgery and anesthesia during pregnancy. To maintain normal fetal oxygenation, maintenance of normal maternal oxygenation and uteroplacental perfusion are critical.
Transient mild decreases in maternal oxygenation are well tolerated by the fetus, because of the high affinity of fetal hemoglobin for oxygen. Severe, prolonged maternal hypoxemia results in fetal hypoxia or even fetal death. Any anesthetic complication that causes profound maternal hypoxemia is a potential threat to the fetus [63] .
Both maternal hypercapnia and maternal hyperventilation can cause fetal problems. Hypercapnia results in fetal acidosis [64] . Maternal hyperventilation adversely affects fetal oxygenation: umbilical artery vasoconstriction, leftward shift of the oxyhemoglobin dissociation curve and reduction in maternal cardiac output as a result of positive pressure ventilation are all consequences of maternal hyperventilation.
Maternal hypotension from any cause can jeopardize fetal well-being by reducing uteroplacental perfusion. Prompt treatment using intravenous fluids, careful positioning with a wedge to avoid aorto-caval compression, reducing the depth of anesthesia or vasopressors is mandatory. Recently, the alpha-adrenergic agent phenylephrine has been reappraised as the agent of choice for treating maternal hypotension [63] .
Direct Fetal Circulatory Effects of Anesthetic Agents
The volatile anesthetic agents have direct depressant effects on the fetal cardiovascular system. Especially when high concentrations of volatile agents are used fetal acidosis might occur. Low-to-moderate concentrations ( ! 1.5 MAC) seem to be devoid of fetal effects in pregnant ewes [65] . However, especially during open fetal surgery, high concentrations are used regularly to provide uterine relaxation. This might be detrimental for the fetus, especially if surgery is prolonged.
Systemic drugs such as opioids and induction agents produce fetal anesthesia, reduce the fetal heart rate variability but do not result in fetal acidosis as long as maternal hemodynamics remain stable [66] . Maternally administered muscle relaxants have little or no effects on the fetus because of their low placental passage [52] .
Evidence that the Fetus Experiences Pain or Responds to Noxious Stimuli
The question of whether a fetus experiences pain is an immense challenge. The issue demands consideration of the physical and psychological basis of being and the relation between the two [67] . There is no objective measurement of 'pain'; it is a subjective experience. The fetus is unable to tell us if it feels pain, so other evidence must be used to decide whether the fetus feels pain. Because of the obvious difficulties in studying fetal behavior, activation of the hypothalamo-pituitary-adrenal (HPA) axis (the 'stress response') has been proposed as a surrogate indicator of fetal pain [68] . This has limitations: stress responses do not necessarily signify pain (for example, during exercise), and stress responses do not involve the cortex. However, the converse is the null hypothesis, i.e. in the absence of a stress response the fetus is unlikely to experience pain.
Hormonal Responses Due largely to the research work of Anand [69] , we are aware that preterm neonates have hormonal stress responses following invasive interventions. These hormonal responses can be prevented by analgesia. As a result, similar studies were performed in the unborn child. Activation of the fetal HPA axis stress response can be assessed by measuring stress hormones such as noradrenaline, cortisol, ␤ -endorphin and corticotrophin. Fisk and colleagues [70, 71] studied samples obtained prior to and following in utero fetal blood transfusion and compared the levels of these hormones before transfusion (immediately after access to the fetal circulation was established) with the levels at the end of transfusion (just before the Van needle was removed). Fetal plasma was obtained during fetal blood sampling for intrauterine transfusion either by needling the fetal intrahepatic vein or by needling the placental cord insertion. Since the placental cord insertion is not innervated, no stress response was observed, whereas in the intrahepatic vein-transfused fetus a significant increase in stress hormones was recorded. The fetal HPA system is functional from at least the beginning of the second trimester.
Hemodynamic Responses
It is well known from animal studies that the fetus in late gestation has a remarkable capacity to redistribute its blood flow in response to acute stressors (hypoxemia, hemorrhage) to protect its more vital organs, such as the brain and myocardium, and this at the expense of other organs such as gut, kidneys and the extremities. Similarly, some chronic stressors, such as sustained hypoxemia or prolonged reductions in uterine blood flow, were also associated with increased brain blood flow. In the human fetus, Doppler ultrasonography studies have shown an association between chronic hypoxemia of intrauterine growth restriction and redistribution of blood flow [72] . Fisk et al. [71] demonstrated that acute painful stimuli (transgression of the fetal abdominal wall during in utero transfusion) were associated with a significant hemodynamic response in the fetus. This hemodynamic stress response is consistent with the redistribution of blood supply to the brain.
Anatomical Considerations [73] To experience pain an intact system of pain transmission from the peripheral receptor to the cerebral cortex must be available. Peripheral receptors develop from the seventh gestational week. From 20 weeks' gestation peripheral receptors are present on the whole body. From 13 weeks' gestation the afferent system located in the substantia gelatinosa of the dorsal horn of the spinal cord starts developing. Development of afferent fibers connecting peripheral receptors with the dorsal horn starts at 8 weeks' gestation. Spinothalamic connections start to develop from 14 weeks' and are complete at 20 weeks' gestation, whilst thalamocortical connections are present from 17 weeks' and completely developed at 26-30 weeks' gestation. From 16 weeks' gestation pain transmission from a peripheral receptor to the cortex is possible and completely developed from 26 weeks' gestation. It is important to note that serotonine-releasing inhibitory descending pain fibers only develop following birth [74] .
The Need for Adequate Fetal Anesthesia
Whether a fetus is capable of experiencing pain as a conscious and emotional feeling remains unclear and is subject to great debate [67] , but we cannot deny that the fetal nervous system mounts protective responses to tissue injury. A physiological fetal reaction to painful stimuli occurs from between 16 and 24 weeks' gestation on.
The fetal nervous system mounts protective responses to tissue injury. The evidences for early exposure to noxious stimuli resulting in adverse effects on future neural development are increasing. This means noxious stimulation may not need to penetrate consciousness in order to substantially alter the course of sensory development. Ruda [75] reported localized inflammation during the neonatal period permanently alters neuronal circuits that process pain in the spinal cord. Preterm neonates who had experienced 4 weeks of NICU (neonatal intensive care unit) therapy manifested decreased behavioral responses and increased cardiovascular responses to the pain of a heel prick as compared to neonates born at 32 weeks. Differences in these response patterns were strongly correlated with the number of invasive procedures experienced since birth, rather than other clinical factors (such as age, Apgar score, birth weight, severity of illness or weight at 32 weeks postconception) [76] . These data suggest that repetitive pain and stress may alter the neurologic substrate associated with pain, leading to altered neurobehavioral responses from subsequent pain in preterm neonates.
According to Anand et al. [77] , repetitive pain in neonatal rat pups may lead to an altered development of the pain system associated with decreased pain thresholds during development. Increased plasticity of the neonatal brain may allow these and other changes in brain development to increase their vulnerability to stress disorders and anxiety-mediated adult behavior [78] . Similar behavioral changes have been observed during later childhood of ex-preterm neonates who were exposed to prolonged periods of neonatal intensive care [69] . Recent studies suggest that although early painful memories are not accessible to conscious recall, they may be encoded in 'procedural memory' and lead to abnormal behavioral patterns or altered sensory processing in later life. Taddio et al. [79] demonstrated that children undergoing a ritual circumcision immediately after birth (without pain relief) react much more vigorously to painful stimuli later in life such as vaccination at 2 months of age.
It is becoming increasingly clear that experiences of pain will be 'remembered' by the developing nervous system, perhaps for the entire life of the individual. These findings should focus the attention of clinicians on the long-term impact of early painful experiences, and highlight the urgent need for developing therapeutic strategies for the management of neonatal and fetal pain. ( table 1 ) [35] Fetal anesthesia can be necessary for prevention of fetal movements and it can also help to reduce the fetal physiologic responses to noxious stimulation, possibly reducing any long-term consequences.
Fetal Anesthetic Techniques
Fisk et al. [71] showed that direct administration of 10 g/kg fentanyl intravenously to the fetus blunts the fetal stress response to intrauterine needling. The magnitude of the ␤ -endorphin and cortisol response was halved, and the cerebral Doppler response was ablated.
Open Fetal Surgery and EXIT Procedures
During open fetal surgery and EXIT procedures under maternal general anesthesia, inhalational agents are considered to provide adequate fetal anesthesia and produce uterine relaxation essential for successful surgery. So, additional analgesia for the fetus is unnecessary. Direct fetal administration of fentanyl and muscle relaxation is reserved for cases where the fetus moves during the procedure. Also when an EXIT procedure is performed under maternal regional anesthesia, specific fetal anesthesia is needed to avoid fetal movements.
Fetal analgesia and muscle relaxation can be given intramuscularly, for example fentanyl 10 g/kg and pancuronium or vecuronium 0.2 mg/kg. Fetal resuscitation drugs should also be ready for the surgeon to administer if needed, for example atropine 0.02 mg/kg and adrenaline 1 g/kg [35] .
Fetal monitoring during the procedure is possible with fetal pulse oximetry and near-infrared spectroscopy for fetal oxygenation monitoring, fetal echocardiography, a fetal scalp electrode for heart rate monitoring and fetal umbilical blood sampling for fetal blood gases and acid base status [80] [81] [82] .
Fetal transfusion blood should be available; blood group O rhesus negative leukocyte-free blood is used in aliquots of 5 ml/kg.
Minimally Invasive Fetal Surgery
Some endoscopic procedures performed directly on the fetus, such as tracheal occlusion or repair of meningomyelocele, are usually performed under maternal local or regional anesthesia. Since these procedures do not require maternal general anesthesia, additional fetal anesthesia is desired and is usually done by direct administration of opioids and muscle relaxants to the fetus. Injection of these drugs in the umbilical cord or intramuscularly into the fetus are two possible routes of administration. At our institution it is also customary to add atropine (0.02-0.03 mg/kg) to the mixture directly administered to the fetus.
The term obstetric endoscopy was proposed for procedures on the placenta, the umbilical cord and fetal membranes. Obstetric endoscopic procedures do not require direct contact with the fetus. The risks of maternal (and consequently fetal) general anesthesia are unlikely to be justified by the degree of stress response inflicted on the fetus. However, immobilization of the fetus is required to prevent accidental fetal movements complicating these procedures. In these instances fetal immobilization is possible using maternally administered sedative drugs such as diazepam. However, we recently determined that remifentanil in doses as low as 0.1 g/kg/min produces effective maternal sedation and fetal immobilization during these procedures and that remifentanil compared favorably to diazepam to produce fetal immobility [38] .
Some authors even suggest providing analgesia to the unborn child in very specific situations such as late pregnancy termination, painful fetal conditions and during vaginal delivery, especially during instrumental vaginal delivery. At the moment the potential side effects of analgesia outweigh the theoretical advantages and we cannot advise on its routine use in these specific situations. Only during late pregnancy termination would we advise to provide fetal analgesia prior to initiation of termination.
Conclusion
Anesthesia for pregnant patients undergoing surgery is demanding because of the increased risks of anesthesia associated with pregnancy. Hemodynamic stability is the cornerstone of good anesthetic management in order to provide a safe environment for the unborn child. Evidence is increasing that from the second trimester onwards, the fetus reacts to painful stimuli and that these painful interventions may cause long-term effects. It is therefore recommended to provide adequate pain relief during potentially painful procedures during in utero life.
